...
首页> 外文期刊>British Biotechnology Journal >Cardiac and Pulmonary Complications in HbE-β Thalassaemia Patients: A Study from West Bengal, Eastern India
【24h】

Cardiac and Pulmonary Complications in HbE-β Thalassaemia Patients: A Study from West Bengal, Eastern India

机译:HbE-β地中海贫血患者的心脏和肺部并发症:来自印度东部西孟加拉邦的一项研究

获取原文

摘要

Aims: Hemoglobinopathies including HbE β thalassemia are associated with significant cardiac and pulmonary compromise in affected persons. The aim of this study was to evaluate the cardiac and pulmonary health of transfusion dependent 50 HbE β thalassemia patients of West Bengal. Study Design: 50 transfusion dependent HbE-β thalassaemia patients were selected to evaluate the pulmonary hypertension as it is often associated with anemia. Place and Duration of Study: Sample: Out Patient Department of Thalassaemia Control Unit, Imambara Sadar Hospital, Chinsurah, Hooghly, West Bengal, India between January, 2014 to December, 2015. Methodology: We have evaluated the ECG, Echocardiography and Chest X ray to assess the cardiac function. Chest X ray and Spirometry (FVC, FEV1, FEV1%, PFC) were also monitored to evaluate the pulmonary obstruction. Results: 68% patients showed severe to moderate pulmonary restriction, where as only 10% patients were found to have no significant pulmonary restrictions. The remaining 22% patients showed mild restriction. Other clinical abnormalities found on these HbE-β thalassaemia patents includes palpitation, chest pain, dyspnoea, edema feet and investigation reveals pulmonary arterial hypertension (PAH), volume overload of left heart, pulmonary arterial enlargement, cardiomegaly and LVH strain pattern. Conclusion: In this study, we have found that 68% of all patients showed reportable pulmonary restrictions. Cardiomegaly, volume overload of left heart and LVH strain pattern was found in 26%, 22% and 16% of all patients respectively. Overall, this study will help to get a clear cut and overall idea about the cardiac and pulmonary health of the HbE-β thalassaemia, which ultimately help in the prospective management of the related complications associated with the disease.
机译:目的:血红蛋白病(包括HbEβ地中海贫血)与受影响人的严重心脏和肺功能损害有关。这项研究的目的是评估依赖输血的西孟加拉邦50名HbEβ地中海贫血患者的心脏和肺部健康。研究设计:选择50例依赖输血的HbE-β地中海贫血患者来评估其经常与贫血相关的肺动脉高压。研究的地点和持续时间:样品:印度西孟加拉邦胡格利,金苏拉,伊姆巴拉巴拉萨达医院地中海贫血症控制部门的门诊部,时间:2014年1月至2015年12月。方法:我们评估了心电图,超声心动图和X线胸片评估心功能。还对胸部X线和肺活量测定(FVC,FEV1,FEV1%,PFC)进行了监测,以评估肺梗阻。结果:68%的患者显示出严重至中度的肺部受限,而只有10%的患者被发现没有明显的肺部受限。其余22%的患者表现出轻度限制。在这些HbE-β地中海贫血专利中发现的其他临床异常包括心itation,胸痛,呼吸困难,浮肿脚,研究发现肺动脉高压(PAH),左心体积超负荷,肺动脉增大,心脏肥大和LVH应变模式。结论:在这项研究中,我们发现68%的患者显示出可报告的肺部限制。在所有患者中,发现心脏肥大,左心体积超负荷和LVH应变模式分别为26%,22%和16%。总体而言,这项研究将有助于获得有关HbE-β地中海贫血的心脏和肺部健康的清晰认识和总体思路,从而最终有助于对与该疾病相关的并发症进行前瞻性治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号